According to Elanco's latest financial reports the company's current revenue (TTM) is $4.41 B. In 2022 the company made a revenue of $4.40 B a decrease over the years 2021 revenue that were of $4.76 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $4.41 B | 0.2% |
2022 | $4.40 B | -7.49% |
2021 | $4.76 B | 45.55% |
2020 | $3.27 B | 6.6% |
2019 | $3.07 B | 0.14% |
2018 | $3.06 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.86 B | -80.45% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $0.22 M | -99.99% | ๐บ๐ธ USA |